Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman A Blaheta

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Nutrition and Cancer|July 13, 2019
Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In VitroJens Mani, Jens Neuschäfer, Christian Resch, et al.
International Immunopharmacology|February 16, 2005
Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cellsWolf-Dietrich Beecken, Tobias Engl, Henry Ogbomo, et al.
Cancers|February 5, 2020
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In VitroJochen Rutz, Sebastian Maxeiner, Saira Justin, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasivenessRoman A Blaheta, Wolf-Dietrich Beecken, Tobias Engl, et al.
Oncotarget|May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
BMC Cancer|August 27, 2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axisSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Cancer Letters|September 20, 2011
The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell lineIgor Tsaur, Jasmina Makarević, Lukasz Hudak, et al.
Molecular and Cellular Endocrinology|July 3, 2021
Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cellsJennifer Schmidt, Elsie Oppermann, Roman A Blaheta, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 19, 2017
Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell linesEva Juengel, Stephanie Euler, Sebastian Maxeiner, et al.
Andrologia|June 24, 2020
Ethanol-extracted Cameroonian propolis: Antiproliferative effects and potential mechanism of action in prostate cancerStéphane Zingue, Sebastian Maxeiner, Jochen Rutz, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Nutrition and Cancer|July 13, 2019
Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In VitroJens Mani, Jens Neuschäfer, Christian Resch, et al.
International Immunopharmacology|February 16, 2005
Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cellsWolf-Dietrich Beecken, Tobias Engl, Henry Ogbomo, et al.
Cancers|February 5, 2020
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In VitroJochen Rutz, Sebastian Maxeiner, Saira Justin, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasivenessRoman A Blaheta, Wolf-Dietrich Beecken, Tobias Engl, et al.
Oncotarget|May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
BMC Cancer|August 27, 2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axisSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Cancer Letters|September 20, 2011
The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell lineIgor Tsaur, Jasmina Makarević, Lukasz Hudak, et al.
Molecular and Cellular Endocrinology|July 3, 2021
Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cellsJennifer Schmidt, Elsie Oppermann, Roman A Blaheta, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 19, 2017
Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell linesEva Juengel, Stephanie Euler, Sebastian Maxeiner, et al.
Andrologia|June 24, 2020
Ethanol-extracted Cameroonian propolis: Antiproliferative effects and potential mechanism of action in prostate cancerStéphane Zingue, Sebastian Maxeiner, Jochen Rutz, et al.
Pageof 13